Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

Atrium Therapeutics, Inc.NASDAQ: RNA

Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other current liabilities of $6.98M in Q1 FY2026

Q1 FY2026 other current liabilities was $6.98M.

Context

  • Other current liabilities amounted to 2.4% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.98M+121.9% QoQ
Last fiscal yearDec 2025
$3.15M— YoY
Other Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Current Liabilities history

USD · from the balance sheet

Latest · FY2025
3.15M USD
Year-over-year change
—

Other Current Liabilities vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Other Current Liabilities figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.